002223.SHE Jiangsu Yuyue Medical Equipment & Supply Co Ltd
- Market cap
- CNY 28.4B
- P/E
- 24.6x
- P/B
- 2.14x
- ROE
- 11.7%
- Dividend yield
- 2.81%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002223.SHE undervalued?
Graham number002223.SHE trades 53.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Jiangsu Yuyue Medical Equipment & Supply Co Ltd fundamental analysis
No fundamental analysis for Jiangsu Yuyue Medical Equipment & Supply Co Ltd yet.
Jiangsu Yuyue Medical Equipment & Supply Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. provides medical devices and health product in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monitors, oximeters, and thermometers; wheelchairs; AEDs; and traditional Chinese medicine product solutions. The company was formerl…
Full company profileJiangsu Yuyue Medical Equipment & Supply Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Jiangsu Yuyue Medical Equipment & Supply Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.64B | 3.54B | 4.18B | 4.64B | 6.73B | 6.89B | 7.10B | 7.97B | 7.57B | 7.96B | 8.82B |
| Gross Profit | 1.02B | 1.40B | 1.67B | 1.95B | 3.54B | 3.31B | 3.39B | 4.06B | 3.77B | 4.02B | 4.40B |
| Operating Income | 541M | 683M | 776M | 850M | 2.01B | 1.69B | 1.84B | 2.89B | 1.93B | 1.50B | 1.66B |
| EBITDA | 562M | 720M | 805M | 891M | 2.17B | 1.68B | 1.59B | 2.24B | 1.63B | 1.96B | 1.66B |
| Net Income | 500M | 592M | 727M | 753M | 1.76B | 1.48B | 1.60B | 2.40B | 1.81B | 1.48B | 1.51B |
| EPS | 0.53 | 0.59 | 0.73 | 0.75 | 1.75 | 1.49 | 1.61 | 2.41 | 1.81 | 1.48 | 1.52 |
| Balance Sheet | |||||||||||
| Total Assets | 5.82B | 6.63B | 6.91B | 7.97B | 10.1B | 12.0B | 15.1B | 16.0B | 15.6B | 16.1B | 16.2B |
| Total Liabilities | 880M | 1.06B | 1.37B | 1.81B | 2.60B | 3.57B | 5.03B | 4.05B | 2.99B | 2.73B | 3.16B |
| Shareholders' Equity | 4.91B | 5.24B | 5.47B | 6.07B | 7.44B | 8.27B | 9.86B | 11.8B | 12.5B | 13.2B | 12.9B |
| Cash & Short-term Investments | 3.27B | 2.05B | 1.67B | 1.56B | 3.39B | 4.67B | 7.35B | 7.29B | 6.74B | 579M | 1.04B |
| Total Debt | 103M | 50.0M | 157M | 150M | 655M | 1.50B | 1.60B | 713M | 19.9M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 677M | 242M | 798M | 614M | 2.83B | 1.20B | 2.30B | 2.13B | 1.82B | 1.50B | - |
| Capital Expenditure | 76.2M | 490M | 390M | 440M | 679M | 284M | 379M | 133M | 128M | 129M | 89.6M |
| Free Cash Flow | 601M | -248M | 409M | 174M | 2.15B | 917M | 1.93B | 1.99B | 1.69B | 1.37B | 1.45B |
| Ratios | |||||||||||
| ROE | 10.2% | 11.3% | 13.3% | 12.4% | 23.7% | 17.9% | 16.2% | 20.4% | 14.4% | 11.2% | 11.7% |
| ROA | 8.6% | 8.9% | 10.5% | 9.4% | 17.4% | 12.4% | 10.6% | 15.0% | 11.5% | 9.2% | 9.3% |
| Net Profit Margin | 18.9% | 16.7% | 17.4% | 16.2% | 26.2% | 21.5% | 22.5% | 30.1% | 23.9% | 18.6% | 17.1% |
| Debt to Equity | 0.02x | 0.01x | 0.03x | 0.02x | 0.09x | 0.18x | 0.16x | 0.06x | 0.00x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Jiangsu Yuyue Medical Equipment & Supply Co Ltd dividends
- Dividend yield
- 2.81%
- Forward dividend
- 1.20 CNY
- Payout ratio
- 53.9%
- Ex-dividend date
- Sep 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 799M | 0.80 | 53.9% |
| 2024 | CNY 1.22B | 1.23 | 67.8% |
| 2023 | CNY 598M | 0.60 | 24.9% |
| 2022 | CNY 351M | 0.35 | 22.0% |
| 2021 | CNY 319M | 0.32 | 21.5% |
| 2020 | CNY 401M | 0.40 | 22.8% |
| 2019 | CNY 159M | 0.16 | 21.2% |
| 2018 | CNY 156M | 0.16 | 21.4% |
| 2017 | CNY 272M | 0.27 | 45.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 15:10 on May 26, 2017.
Who owns Jiangsu Yuyue Medical Equipment & Supply Co Ltd
- Insiders 43.52%
- Institutions 15.50%
- Public & others 40.99%
- Shares outstanding 995M
- Free float 559M
Jiangsu Yuyue Medical Equipment & Supply Co Ltd company profile
- Company name
- Jiangsu Yuyue Medical Equipment & Supply Co Ltd
- Ticker
- 002223.SHE
- ISIN
- CNE1000009X3
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Apr 18, 2008
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 6,676
- Fiscal year end
- December
- Address
- No.1 Baisheng Road, Danyang, China
- Phone
- 86 511 8690 0876
- Website
- yuyue.com.cn
About Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. provides medical devices and health product in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monitors, oximeters, and thermometers; wheelchairs; AEDs; and traditional Chinese medicine product solutions. The company was formerly known as Yuwell medical. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was founded in 1998 and is based in Danyang, China.
Jiangsu Yuyue Medical Equipment & Supply Co Ltd management
10- Mr. Qun WuGM & Chairman · born 1988
- Ms. Lihua LiuFinancial Director · born 1978
- Mr. Shuai ZhaoDeputy GM & Non Independent Director · born 1981
- Mr. Hongzhe ZhengDeputy General Manager · born 1982
- Ms. Ruijie WangDirector & Board Secretary · born 1992
- Mr. Zhang Yong C.F.A.Deputy General Manager · born 1972
- Mr. Wei JingDeputy General Manager · born 1979
- Mr. Caihao YuDeputy General Manager · born 1995
- Mr. Nanxuan XuDeputy General Manager · born 1987
- Yonghong ShiAccounting Supervisor